Molecular Signature of Smoking in Human Lung Tissues
Menée sur 853 échantillons tumoraux prélevés sur des patients atteints d'un cancer du poumon, cette étude identifie des gènes dont l'expression est associée au tabagisme des patients
Cigarette smoking is the leading risk factor for lung cancer. To identify genes deregulated by smoking and to distinguish gene expression changes that are reversible and persistent following smoking cessation, we performed genome-wide gene expression profiling on non-tumor lung tissue from 853 patients with lung cancer. Gene expression levels were compared between never- and current-smokers, and time-dependent changes in gene expression were studied in former-smokers. A total of 3,223 transcripts were differentially expressed between smoking groups in the discovery set (n=344, p<1.29x10-6). A substantial number of smoking-induced genes also were validated in two replication sets (n=285 and 224), and a gene expression signature of 599 transcripts consistently segregated never- from current-smokers across all three sets. The expression of the majority of these genes reverted to never-smoker levels following smoking cessation although the time course of normalization differed widely among transcripts. Moreover, some genes showed very slow or no reversibility in expression, including SERPIND1, which was found to be the most consistent gene permanently altered by smoking in the three sets. Our findings therefore indicate that smoking deregulates many genes, many of which reverse to normal following smoking cessation. However, a subset of genes remains altered even decades following smoking cessation and may account, at least in part, for the residual risk of lung cancer among former-smokers.